Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | 0.1231 | 0.4678 | 0.4678 |
Plasmodium vivax | thymidylate kinase, putative | 0.007 | 0.0125 | 0.0125 |
Mycobacterium ulcerans | orotate phosphoribosyltransferase | 0.0047 | 0.0033 | 0.0033 |
Mycobacterium ulcerans | thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Toxoplasma gondii | thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Trypanosoma cruzi | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0152 | 0.0443 | 0.0443 |
Plasmodium falciparum | orotidine 5'-phosphate decarboxylase | 0.0138 | 0.0388 | 0.0356 |
Mycobacterium ulcerans | FAD-dependent thymidylate synthase | 0.189 | 0.7263 | 0.7263 |
Mycobacterium tuberculosis | Probable orotate phosphoribosyltransferase PyrE (OPRT) (oprtase) | 0.0047 | 0.0033 | 0.0033 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.0125 | 0.0125 |
Mycobacterium leprae | Probable orotidine 5'-phosphate decarboxylase PyrF (OMP decarboxylase) (OMPDCase) (OMPdecase) | 0.0138 | 0.0388 | 0.0388 |
Trypanosoma cruzi | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0152 | 0.0443 | 0.0443 |
Brugia malayi | MH2 domain containing protein | 0.0256 | 0.0854 | 0.0854 |
Schistosoma mansoni | orotidine 5'-phosphate decarboxylase | 0.0152 | 0.0443 | 0.0443 |
Toxoplasma gondii | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase | 0.0138 | 0.0388 | 0.0388 |
Mycobacterium ulcerans | orotidine 5'-phosphate decarboxylase | 0.0138 | 0.0388 | 0.0388 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.007 | 0.0125 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.1231 | 0.4678 | 0.4678 |
Schistosoma mansoni | thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Loa Loa (eye worm) | orotate phosphoribosyltransferase | 0.0152 | 0.0443 | 0.0443 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.007 | 0.0125 | 0.0266 |
Trypanosoma brucei | thymidylate kinase, putative | 0.007 | 0.0125 | 0.0125 |
Plasmodium vivax | orotidine 5'-phosphate decarboxylase, putative | 0.0138 | 0.0388 | 0.0388 |
Trypanosoma brucei | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0152 | 0.0443 | 0.0443 |
Plasmodium vivax | orotate phosphoribosyltransferase, putative | 0.0047 | 0.0033 | 0.0033 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.007 | 0.0125 | 0.0125 |
Loa Loa (eye worm) | thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0256 | 0.0854 | 0.0854 |
Treponema pallidum | thymidylate kinase (tmk) | 0.007 | 0.0125 | 0.5 |
Echinococcus granulosus | thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Leishmania major | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative,OMPDCase-OPRTase, putative | 0.0152 | 0.0443 | 0.0443 |
Trypanosoma brucei | deoxyuridine triphosphatase, putative | 0.0372 | 0.1307 | 0.1307 |
Trypanosoma brucei | thymidylate kinase, putative | 0.007 | 0.0125 | 0.0125 |
Trypanosoma cruzi | deoxyuridine triphosphatase, putative | 0.0372 | 0.1307 | 0.1307 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.007 | 0.0125 | 0.0266 |
Brugia malayi | thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Toxoplasma gondii | orotate phosphoribosyltransferase | 0.0047 | 0.0033 | 0.0033 |
Leishmania major | deoxyuridine triphosphatase, putative,dUTP diphosphatase | 0.0372 | 0.1307 | 0.1307 |
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | 0.007 | 0.0125 | 0.0125 |
Echinococcus multilocularis | thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Leishmania major | thymidylate kinase-like protein | 0.007 | 0.0125 | 0.0125 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0256 | 0.0854 | 0.0854 |
Onchocerca volvulus | 0.0569 | 0.2079 | 0.2079 | |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.007 | 0.0125 | 0.0373 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0247 | 0.0817 | 0.0817 |
Onchocerca volvulus | Putative thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Brugia malayi | orotate phosphoribosyltransferase family protein | 0.0152 | 0.0443 | 0.0443 |
Plasmodium falciparum | thymidylate kinase | 0.007 | 0.0125 | 0.0092 |
Schistosoma mansoni | thymidylate kinase | 0.007 | 0.0125 | 0.0125 |
Mycobacterium leprae | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) | 0.007 | 0.0125 | 0.0125 |
Chlamydia trachomatis | thymidylate kinase | 0.007 | 0.0125 | 0.5 |
Trypanosoma cruzi | deoxyuridine triphosphatase, putative | 0.0372 | 0.1307 | 0.1307 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyX (ts) (TSase) | 0.189 | 0.7263 | 0.7263 |
Wolbachia endosymbiont of Brugia malayi | orotidine-5'-phosphate decarboxylase | 0.0673 | 0.249 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1231 | 0.4678 | 1 |
Brugia malayi | hypothetical protein | 0.1231 | 0.4678 | 0.4678 |
Echinococcus granulosus | uridine 5' monophosphate synthase | 0.0152 | 0.0443 | 0.0443 |
Mycobacterium leprae | PROBABLE OROTATE PHOSPHORIBOSYLTRANSFERASE PYRE (OPRT) (OPRTASE) | 0.0047 | 0.0033 | 0.0033 |
Giardia lamblia | CDC8 | 0.007 | 0.0125 | 0.5 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYX (TS) (TSase) | 0.189 | 0.7263 | 0.7263 |
Echinococcus multilocularis | uridine 5' monophosphate synthase | 0.0152 | 0.0443 | 0.0443 |
Trypanosoma cruzi | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0138 | 0.0388 | 0.0388 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.007 | 0.0125 | 0.0125 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.75 uM | Cytotoxicity against mouse J774 cells assessed as cell viability after 72 hrs by Alamar blue assay | ChEMBL. | 23265887 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 23265887 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.